{"nct_id":"NCT00310388","title":"Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097","status":"TERMINATED","status_verified_date":"2018-10","start_date":"2006-07-05","start_date_type":"ACTUAL","primary_completion_date":"2017-04-18","primary_completion_date_type":"ACTUAL","completion_date":"2018-05-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}